Association of marijuana smoking with oropharyngeal and oral tongue cancers: Pooled analysis from the INHANCE consortium

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 1, 2014, Pages 160-171

  Marks, Morgan A ^a   Chaturvedi, Anil K ^a   Kelsey, Karl ^d   Straif, Kurt ^e   Berthiller, Julien ^e,f,g   Schwartz, Stephen M ⁱ   Smith, Elaine ^j   Wyss, Annah ^k   Brennan, Paul ^e   Olshan, Andrew F ^k   Wei, Qingyi ^l   Sturgis, Erich M ^l   Zhang, Zuo Feng ^m   Morgenstern, Hal ⁿ   Muscat, Joshua ^o   Lazarus, Philip ^o   McClean, Michael ^p   Chen, Chu ⁱ   Vaughan, Thomas L ⁱ   Wunsch Filho, Victor ^q   Curado, Maria Paula ^h   Koifman, Sergio ^r   Matos, Elena ^u   Menezes, Ana ^s   Daudt, Alexander W ^t   Fernandez, Leticia ^v   Posner, Marshall ^b   Boffetta, Paolo ^h,w   Amy Lee, Yuan Chin ^x   Hashibe, Mia ^x   D'Souza, Gypsyamber ^c   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d BROWN UNIVERSITY   (United States)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f HOSPICES CIVILS DE LYON   (France)

^g UNIVERSITÉ LYON 1   (France)

^h INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

ⁱ Fred Hutchinson Cancer Research Center   (United States)

^j UNIVERSITY OF IOWA   (United States)

^k IL   (United States)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^o PENN STATE COLLEGE OF MEDICINE   (United States)

^p BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^q UNIVERSITY OF SÃO PAULO   (Brazil)

^r INSTITUTO OSWALDO CRUZ   (Brazil)

^s FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^t HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^u UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^v INSTITUTO NACIONAL DE ONCOLOGÍA Y RADIOBIOLOGÍA   (Cuba)

^w MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^x UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANNABIS SMOKING; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HIGH RISK BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OROPHARYNX CANCER; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SENSITIVITY ANALYSIS; SMOKING; SOUTH AND CENTRAL AMERICA; TONGUE CANCER; UNITED STATES;

ADULT; AGED; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; LATIN AMERICA; MALE; MARIJUANA SMOKING; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; RISK FACTORS; TOBACCO USE; TONGUE NEOPLASMS; UNITED STATES;

EID: 84892684826     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0181     Document Type: Article

References (47)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Gillison ML, Lowy DR. A causal role for human papillomavirus in head and neck cancer. Lancet 2004;363:1488-9.
3. Blomberg M, Nielsen A, Munk C, Kjaer SK. Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites. Int J Cancer 2010;129:733-41.
4. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-9.
5. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer 2005;103:1843-9.
6. Patel SC, Carpenter WR, Tyree S, Couch ME, Weissler M, Hackman T, et al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol 2011;29: 1488-94.
7. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-301.
8. Lingen MW, Xiao W, Schmidt A, Jiang B, Pickard R, Kreinbrink P, et al. Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 2012;49:1-8.
9. Hashibe M, Straif K, Tashkin DP, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005;35:265-75.
10. Johnson RA, Gerstein DR. Initiation of use of alcohol, cigarettes, marijuana, cocaine, and other substances in US birth cohorts since 1919. Am J Public Health 1998;88:27-33.
11. Schantz SP, Yu GP. Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer. Arch Otolaryngol Head Neck Surg 2002;128:268-74.
12. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-20.
13. Liang C, McClean MD, Marsit C, Christensen B, Peters E, Nelson HH, et al. A population-based case-control study of marijuana use and head and neck squamous cell carcinoma. Cancer Prev Res 2009;2: 759-68.
14. Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, et al. Cannabis use and cancer of the head and neck: case-control study. Otolaryngol Head Neck Surg 2008;138:374-80.
15. Berthiller J, Lee YC, Boffetta P, Wei Q, Sturgis EM, Greenland S, et al. Marijuana smoking and the risk of head and neck cancer: pooled analysis in the INHANCE consortium. Cancer Epidemiol Biomarkers Prev 2009;18:1544-51.
16. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med 2004;33: 525-32.
17. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya KA. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: a descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol 2003;39:106-14.
18. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol 2004;40:304-13.
19. Rosenblatt KA, Daling JR, Chen C, Sherman KJ, Schwartz SM. Marijuana use and risk of oral squamous cell carcinoma. Cancer Res 2004;64:4049-54.
20. Zhang ZF, Morgenstern H, Spitz MR, Tashkin DP, Yu GP, Marshall JR, et al. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999;8:1071-8.
21. Conway DI, Hashibe M, Boffetta P, Wunsch-Filho V, Muscat J, La Vecchia C, et al. Enhancing epidemiologic research on head and neck cancer: INHANCE - The international head and neck cancer epidemiology consortium. Oral Oncol 2009;45:743-6.
22. Purdue MP, Hashibe M, Berthiller J, La Vecchia C, Dal Maso L, Herrero R, et al. Type of alcoholic beverage and risk of head and neck cancer-a pooled analysis within the INHANCE Consortium. Am J Epidemiol 2009;169:132-42.
23. Edwards S, Carne C. Oral sex and the transmission of viral STIs. Sex Transm Infect 1998;74:6-10.
24. Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis 2005;41:67-74.
25. Richardson DB, Kaufman JS. Estimation of the relative excess risk due to interaction and associated confidence bounds. Am J Epidemiol 2009;169:756-60.
26. Steenland K, Greenland S. Monte Carlo sensitivity analysis and Bayesian analysis of smoking as an unmeasured confounder in a study of silica and lung cancer. Am J Epidemiol 2004;160:384-92.
27. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356:1944-56.
28. Gillison ML, Broutian T, Pickard RK, Tong ZY, Xiao W, Kahle L, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703.
29. Rothman K, Greenland S. Modern Epidemiology. Baltimore, MD: Lippincott Williams & Wilkins; 1998. p. 347-50.
30. Greenland S. Basic methods for sensitivity analysis of biases. Int J Epidemiol 1996;25:1107-16.
31. Buchan BJ, L Dennis M, Tims FM, Diamond GS. Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction 2002;97(Suppl 1):98-108.
32. Trivers KF, Mertens AC, Ross JA, Steinbuch M, Olshan AF, Robison LL. Parental marijuana use and risk of childhood acute myeloid leukaemia: a report from the Children's Cancer Group (United States and Canada). Paediatr Perinat Epidemiol 2006;20:110-8.
33. Miech R, Koester S. Trends in U.S., past-year marijuana use from 1985 to 2009: an age-period-cohort analysis. Drug Alcohol Depend 2012;124:259-67.
34. Parks KA, Collins RL, Derrick JL. The influence of marijuana and alcohol use on condom use behavior: findings from a sample of young adult female bar drinkers. Psychol Addict Behav 2012;26:888-94.
35. Bryan AD, Schmiege SJ, Magnan RE. Marijuana use and risky sexual behavior among high-risk adolescents: trajectories, risk factors, and event-level relationships. Dev Psychol 2012;48:1429-42.
36. Gertsch J, Raduner S, Altmann KH. New natural noncannabinoid ligands for cannabinoid type-2 (CB2) receptors. J Recept Signal Transduct Res 2006;26:709-30.
37. Berglund BA, Boring DL, Howlett AC. Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils. Adv Exp Med Biol 1999;469:527-33.
38. Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005;5:400-11.
39. Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, et al. The cannabinoid system and immune modulation. J Leukoc Biol 2003;74: 486-96.
40. Cabral GA, Dove Pettit DA. Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol 1998;83:116-23.
41. McKallip RJ, Nagarkatti M, Nagarkatti PS. Delta-9-tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune response. J Immunol 2005;174:3281-9.
42. Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP, et al. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol 2000;165:373-80.
43. Flygare J, Sander B. The endocannabinoid system in cancer-potential therapeutic target? Semin Cancer Biol 2008;18:176-89.
44. Greenhough A, Patsos HA, Williams AC, Paraskeva C. The cannabinoid delta(9)-tetrahydrocannabinol inhibits RAS-MAPK and PI3K-AKT survival signalling and induces BAD-mediated apoptosis in colorectal cancer cells. Int J Cancer 2007;121:2172-80.
45. Whyte DA, Al-Hammadi S, Balhaj G, Brown OM, Penefsky HS, Souid AK. Cannabinoids inhibit cellular respiration of human oral cancer cells. Pharmacology 2010;85:328-35.
46. Parolaro D, Massi P. Cannabinoids as potential new therapy for the treatment of gliomas. Expert Rev Neurother 2008;8:37-49.
47. Guindon J, Hohmann AG. The endocannabinoid system and cancer: therapeutic implication. Br J Pharmacol 2011;163: 1447-63.